You are now leaving

The link you have selected will take you outside of ADMA Biologics corporate website. The site you will be entering is intended for U.S. audiences only. Do you wish to continue?

HCP Disclosure Reporting

Colorado Disclosure Act

Colorado law HB 19-1131 requires pharmaceutical manufacturers, when engaging in prescription drug marketing, to provide the wholesale acquisition cost (WAC) of the drug to Colorado prescribers. Under Colorado law, the names of generic prescription drugs (if available) from the same therapeutic class (i.e., same or similar mechanism of action used to treat a specific condition) shall also be provided.

ADMA Biologics has listed these therapeutic class prices in Short Form Disclosures as required under Colorado Law.